Cathelicidins modulate TLR-activation and inflammation

MR Scheenstra, RM Van Harten… - Frontiers in …, 2020 - frontiersin.org
Cathelicidins are short cationic peptides that are part of the innate immune system. At first,
these peptides were studied mostly for their direct antimicrobial killing capacity, but …

Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors

T Ye, W Tao, X Chen, C Jiang, B Di, L Xu - Cytokine & growth factor reviews, 2023 - Elsevier
The Nucleotide-binding domain leucine-rich repeat and pyrin domain containing receptor 3
(NLRP3), a member of the nucleotide-binding oligomerization domain (NOD) like receptors …

The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?

B Kashani, Z Zandi… - Journal of cellular …, 2021 - Wiley Online Library
The toll‐like receptor (TLR) family consists of vital receptors responsible for pattern
recognition in innate immunity, making them the core proteins involved in pathogen …

Dock-family exchange factors in cell migration and disease

G Gadea, A Blangy - European journal of cell biology, 2014 - Elsevier
Dock family proteins are evolutionary conserved exchange factors for the Rho GTPases Rac
and Cdc42. There are 11 Dock proteins in mammals, named Dock1 (or Dock180) to Dock11 …

RAGE inhibitors for targeted therapy of cancer: a comprehensive review

T Faruqui, MS Khan, Y Akhter, S Khan, Z Rafi… - International Journal of …, 2022 - mdpi.com
The receptor for advanced glycation end products (RAGE) is a member of the
immunoglobulin family that is overexpressed in several cancers. RAGE is highly expressed …

Construction of probiotic double-layered multinucleated microcapsules based on sulfhydryl-modified carboxymethyl cellulose sodium for increased intestinal adhesion …

H Zhang, Z Liu, H Fang, S Chang, G Ren… - … Applied Materials & …, 2023 - ACS Publications
The decreased number of viable bacteria and the ability of Bifidobacterium to adhere to and
colonize the gut in the gastrointestinal environment greatly limit their efficacy. To solve this …

Trial Watch: Toll-like receptor agonists for cancer therapy

E Vacchelli, A Eggermont, C Sautès-Fridman… - …, 2013 - Taylor & Francis
Toll-like receptors (TLRs) have long been known for their ability to initiate innate immune
responses upon exposure to conserved microbial components such as lipopolysaccharide …

[HTML][HTML] The role of toll-like receptors (TLRs) mediated inflammation in pancreatic cancer pathophysiology

A Orlacchio, P Mazzone - International Journal of Molecular Sciences, 2021 - mdpi.com
Pancreatic cancer (PC) is one of the most lethal forms of cancer, characterized by its
aggressiveness and metastatic potential. Despite significant improvements in PC treatment …

CD90+ stromal cells are the major source of IL‐6, which supports cancer stem‐like cells and inflammation in colorectal cancer

PT Huynh, EJ Beswick, YA Coronado… - … journal of cancer, 2016 - Wiley Online Library
IL‐6 is a pleiotropic cytokine increased in CRC and known to directly promote tumor growth.
Colonic myofibroblasts/fibroblasts (CMFs or stromal cells) are CD90+ innate immune cells …

Toll-like receptor-4 modulation for cancer immunotherapy

S Awasthi - Frontiers in immunology, 2014 - frontiersin.org
IntroductionToll-like receptors (TLRs) are evolutionarily conserved pattern recognition
molecules. Since the discovery of the Toll pathway cascade (1, 2), our knowledge about the …